AT301749B - Verfahren zur Herstellung eines Inhibitors pathologischer Prozesse, insbesondere Leukämie und Sarcome - Google Patents

Verfahren zur Herstellung eines Inhibitors pathologischer Prozesse, insbesondere Leukämie und Sarcome

Info

Publication number
AT301749B
AT301749B AT1170570A AT1170570A AT301749B AT 301749 B AT301749 B AT 301749B AT 1170570 A AT1170570 A AT 1170570A AT 1170570 A AT1170570 A AT 1170570A AT 301749 B AT301749 B AT 301749B
Authority
AT
Austria
Prior art keywords
sarcoma
inhibitor
production
pathological processes
particular leukemia
Prior art date
Application number
AT1170570A
Other languages
German (de)
English (en)
Inventor
Jean-Claude Dr Chermann
Claude Dr Jasmin
Georges Mathe
Marcel Dr Reynaud
Original Assignee
Pasteur Institut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Institut filed Critical Pasteur Institut
Application granted granted Critical
Publication of AT301749B publication Critical patent/AT301749B/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/21—Retroviridae, e.g. equine infectious anemia virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/13—Tumour cells, irrespective of tissue of origin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/26—Lymph; Lymph nodes; Thymus; Spleen; Splenocytes; Thymocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/205—Rhabdoviridae, e.g. rabies virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/20011—Rhabdoviridae
    • C12N2760/20211—Vesiculovirus, e.g. vesicular stomatitis Indiana virus
    • C12N2760/20234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Mycology (AREA)
  • Zoology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT1170570A 1969-12-31 1970-12-29 Verfahren zur Herstellung eines Inhibitors pathologischer Prozesse, insbesondere Leukämie und Sarcome AT301749B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR6945776A FR2073293B1 (ja) 1969-12-31 1969-12-31

Publications (1)

Publication Number Publication Date
AT301749B true AT301749B (de) 1972-09-11

Family

ID=9045518

Family Applications (1)

Application Number Title Priority Date Filing Date
AT1170570A AT301749B (de) 1969-12-31 1970-12-29 Verfahren zur Herstellung eines Inhibitors pathologischer Prozesse, insbesondere Leukämie und Sarcome

Country Status (11)

Country Link
JP (1) JPS4940922B1 (ja)
AT (1) AT301749B (ja)
BE (1) BE760727A (ja)
CA (1) CA956573A (ja)
CH (1) CH533988A (ja)
DE (1) DE2064296C2 (ja)
DK (1) DK128054B (ja)
FR (1) FR2073293B1 (ja)
GB (1) GB1326928A (ja)
LU (1) LU62332A1 (ja)
NL (1) NL7019097A (ja)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5330639U (ja) * 1976-08-20 1978-03-16
CH664494A5 (it) * 1979-10-11 1988-03-15 Liborio Dott Bonifacio Procedimento per preparare antidoti per la prevenzione e la cura dei tumori, dagli escrementi delle capre.
JPS5925332A (ja) * 1982-08-04 1984-02-09 Mochida Pharmaceut Co Ltd 抗腫瘍性糖蛋白質の製法
FR2568125B1 (fr) * 1984-07-25 1988-04-15 Kogo Michiko Agent anti-tumeur contenant la proteine du sucre
GB8614733D0 (en) * 1986-06-17 1986-07-23 Lefesvre A Aids treatment

Also Published As

Publication number Publication date
CA956573A (en) 1974-10-22
LU62332A1 (ja) 1971-05-27
BE760727A (fr) 1971-05-27
FR2073293A1 (ja) 1971-10-01
CH533988A (fr) 1973-02-28
FR2073293B1 (ja) 1973-01-12
GB1326928A (en) 1973-08-15
DE2064296A1 (de) 1971-07-15
NL7019097A (ja) 1971-07-02
JPS4940922B1 (ja) 1974-11-06
DK128054B (da) 1974-02-25
DE2064296C2 (de) 1984-10-25

Similar Documents

Publication Publication Date Title
CH526630A (de) Verfahren zur Herstellung eines Enzymproduktes
CH542883A (de) Verfahren zur Herstellung von komplexen Aluminiumphosphaten
AT320268B (de) Verfahren zur Herstellung von rotationssymmetrischen Formkörpern, insbesondere Linsen
CH520558A (de) Verfahren und Vorrichtung zur Herstellung von Folien
AT302989B (de) Verfahren zur Herstellung von Bromnitroalkoholen
CH553747A (de) Verfahren zur herstellung von alkanolaminderivaten.
CH548972A (de) Verfahren zur herstellung von norbornylderivaten.
AT305417B (de) Verfahren zur Herstellung von Schaltkreisen
CH519356A (de) Verfahren und Vorrichtung zur Herstellung von stabförmigem Walzgut
AT303924B (de) Verfahren zur Herstellung kochfester, sterilisier- und hochverformbarer Lackfilme
CH516826A (de) Verfahren zur Herstellung von Reliefformen
CH507572A (fr) Verfahren und Vorrichtung zur Kennzeichnung eines isolierten elektrischen Leiters
AT301749B (de) Verfahren zur Herstellung eines Inhibitors pathologischer Prozesse, insbesondere Leukämie und Sarcome
AT301512B (de) Verfahren zur Herstellung von Aldehyden und Alkoholen
AT324257B (de) Verfahren und vorrichtung zur herstellung von reissverschlüssen
CH558799A (de) Verfahren zur herstellung von naphthalimidderivaten.
AT303563B (de) Verfahren zur Herstellung von Formkörpern, insbesondere von Schleifkörpern
CH535964A (de) Verfahren und Anordnung zur Herstellung von Punkthologrammen
CH538540A (de) Verfahren zur Herstellung eines Enzympräparates
CH542176A (de) Verfahren zur Herstellung von Polyaminen
AT314395B (de) Verfahren zur Herstellung eines Effektgarns
CH489218A (de) Verfahren zur Herstellung eines Schuhwerkes oder Teilen davon, und Vorrichtung zur Durchführung des Verfahrens
AT320718B (de) Verfahren zur Herstellung von Kabeln und Vorrichtung hierzu
AT301504B (de) Verfahren zur Herstellung von Alkoholen
CH552014A (de) Verfahren zur herstellung komplexer aluminium- und aluminium-chrom-salze.

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee